Orchestra BioMed Holdings, Inc. SEC filings OBIO

Orchestra BioMed Holdings, Inc. has 412 filings in SEC EDGAR's recent list, going back to Jun 22, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Orchestra BioMed Holdings, Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
10-K Annual report Mar 12, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 30, 2024 Dec 31, 2023
10-K Annual report Mar 27, 2024 Dec 31, 2023
10-K Annual report Jan 25, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K/A Amended annual report Mar 31, 2022 Dec 31, 2020
10-K Annual report Mar 10, 2021 Dec 31, 2020

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
OBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Hope, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1814114
Former names
Health Sciences Acquisitions Corp 2 (until Jan 26, 2023)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.